LY2062430 Uses, Dosage, Side Effects and more
LY2062430 is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.
| Attribute | Details |
|---|---|
| Trade Name | LY2062430 |
| Generic | Solanezumab |
| Solanezumab Other Names | LY2062430, Solanezumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
